Imunon, Inc. Basic Shares Outstanding (Weighted Average)
Imunon, Inc. (IMNN) reported Basic Shares Outstanding (Weighted Average) of 5.23 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-11
- Imunon, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 5.23M shares, a 309.69% increase year-over-year.
- Imunon, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 5.03M shares, a 286.55% increase year-over-year.
- Imunon, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 2.93M shares, a 124.40% increase year-over-year.
- Imunon, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 2.94M shares, a 128.22% increase year-over-year.
- Imunon, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 2.12M shares, a 93.22% increase from fiscal 2024.
- Imunon, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 1.10M shares, a 87.85% decline from fiscal 2023.
- Imunon, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 9.05M shares, a 26.63% increase from fiscal 2022.
- Imunon, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 7.14M shares, a 31.62% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 5.23M shares 10-Q · filed 2026-08-11 | 5.13M shares 10-Q · filed 2026-08-11 | 4.40M shares derived: average of 3 quarters · filed 2026-08-11 | 4.03M shares derived: average of 4 quarters · filed 2026-08-11 | ||||
| 2026-03-31 | 5.03M shares 10-Q · filed 2026-05-12 | 3.98M shares derived: average of 2 quarters · filed 2026-05-12 | 3.63M shares derived: average of 3 quarters · filed 2026-05-12 | 3.04M shares derived: average of 4 quarters · filed 2026-08-11 | ||||
| 2025-12-31 | 2.93M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 2.93M shares derived: average of 2 quarters · filed 2026-03-31 | 2.38M shares derived: average of 3 quarters · filed 2026-08-11 | 2.12M shares 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | 2.94M shares 10-Q · filed 2025-11-13 | 2.11M shares derived: average of 2 quarters · filed 2026-08-11 | 1.86M shares 10-Q · filed 2025-11-13 | 1.71M shares derived: average of 4 quarters · filed 2026-08-11 | ||||
| 2025-06-30 | 1.28M shares 10-Q · filed 2026-08-11 | 1.12M shares 10-Q · filed 2026-08-11 | 1.29M shares derived: average of 3 quarters · filed 2026-08-11 | 1.29M shares derived: average of 4 quarters · filed 2026-08-11 | ||||
| 2025-03-31 | 1.30M shares 10-Q · filed 2026-05-12 | 14.56M shares 10-Q · filed 2025-05-12 | 1.30M shares derived: average of 2 quarters · filed 2026-05-12 | 1.30M shares derived: average of 3 quarters · filed 2026-05-12 | 1.13M shares derived: average of 4 quarters · filed 2026-05-12 | |||
| 2024-12-31 | 1.30M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 1.30M shares derived: average of 2 quarters · filed 2026-03-31 | 1.07M shares derived: average of 3 quarters · filed 2026-03-31 | 1.10M shares 10-K · filed 2026-03-31 | 11.51M shares 10-K · filed 2025-02-27 | |||
| 2024-09-30 | 1.29M shares 10-Q · filed 2025-11-13 | 14.45M shares 10-Q · filed 2024-11-07 | 958.27K shares derived: average of 2 quarters · filed 2025-11-13 | 1.03M shares 10-Q · filed 2025-11-13 | 10.50M shares 10-Q · filed 2024-11-07 | 5.18M shares derived: average of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | 626.73K shares 10-Q · filed 2025-08-05 | 9.40M shares 10-Q · filed 2024-08-14 | 626.73K shares 10-Q · filed 2025-08-05 | 9.40M shares 10-Q · filed 2024-08-14 | 6.48M shares derived: average of 3 quarters · filed 2025-08-05 | 7.20M shares derived: average of 4 quarters · filed 2025-08-05 | ||
| 2024-03-31 | 9.40M shares 10-Q · filed 2025-05-12 | 9.40M shares derived: average of 2 quarters · filed 2025-05-12 | 9.39M shares derived: average of 3 quarters · filed 2025-05-12 | 9.33M shares derived: average of 4 quarters · filed 2025-05-12 | ||||
| 2023-12-31 | 9.40M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 9.39M shares derived: average of 2 quarters · filed 2025-02-27 | 9.31M shares derived: average of 3 quarters · filed 2025-02-27 | 9.05M shares 10-K · filed 2025-02-27 | ||||
| 2023-09-30 | 9.38M shares 10-Q · filed 2024-11-07 | 9.26M shares derived: average of 2 quarters · filed 2024-11-07 | 8.93M shares 10-Q · filed 2024-11-07 | 8.88M shares derived: average of 4 quarters · filed 2024-11-07 | ||||
| 2023-06-30 | 9.14M shares 10-Q · filed 2024-08-14 | 8.71M shares 10-Q · filed 2024-08-14 | 8.71M shares derived: average of 3 quarters · filed 2024-08-14 | 8.31M shares derived: average of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | 8.28M shares 10-Q · filed 2024-05-13 | 8.49M shares derived: average of 2 quarters · filed 2024-05-13 | 8.03M shares derived: average of 3 quarters · filed 2024-05-13 | 7.77M shares derived: average of 4 quarters · filed 2024-05-13 | ||||
| 2022-12-31 | 8.71M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | 7.90M shares derived: average of 2 quarters · filed 2024-03-28 | 7.60M shares derived: average of 3 quarters · filed 2024-03-28 | 7.14M shares 10-K · filed 2024-03-28 | ||||
| 2022-09-30 | 7.10M shares 10-Q · filed 2023-11-14 | 7.04M shares derived: average of 2 quarters · filed 2023-11-14 | 6.62M shares 10-Q · filed 2023-11-14 | 6.41M shares derived: average of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | 6.98M shares 10-Q · filed 2023-08-10 | 6.37M shares 10-Q · filed 2023-08-10 | 6.18M shares derived: average of 3 quarters · filed 2023-08-10 | 6.07M shares derived: average of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | 5.77M shares 10-Q · filed 2023-05-11 | 5.77M shares derived: average of 2 quarters · filed 2023-05-11 | 5.77M shares derived: average of 3 quarters · filed 2023-05-11 | 5.76M shares derived: average of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | 5.77M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | 5.77M shares derived: average of 2 quarters · filed 2023-03-30 | 5.76M shares derived: average of 3 quarters · filed 2023-03-30 | 5.43M shares 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | 5.77M shares 10-Q · filed 2022-11-14 | 5.75M shares derived: average of 2 quarters · filed 2022-11-14 | 5.31M shares 10-Q · filed 2022-11-14 | |||||
| 2021-06-30 | 5.73M shares 10-Q · filed 2022-08-15 | 5.08M shares 10-Q · filed 2022-08-15 | ||||||
| 2021-03-31 | 1.72M shares 10-Q · filed 2022-05-16 | |||||||
| 2014-06-30 | 17.53M shares 10-Q · filed 2014-08-07 | 16.93M shares 10-Q · filed 2014-08-07 | ||||||
| 2013-06-30 | 12.09M shares 10-Q · filed 2014-08-07 | 54.39M shares 10-Q · filed 2013-08-08 | 10.81M shares 10-Q · filed 2014-08-07 | 48.63M shares 10-Q · filed 2013-08-08 | ||||
| 2012-06-30 | 33.24M shares 10-Q · filed 2013-08-08 | 33.21M shares 10-Q · filed 2013-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |